CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 249 filers reported holding CONMED CORP in Q4 2020. The put-call ratio across all filers is 2.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,666 | -25.4% | 224,749 | +0.6% | 0.13% | -17.6% |
| Q2 2023 | $30,364 | +23.5% | 223,449 | -5.6% | 0.15% | +23.4% |
| Q1 2023 | $24,583 | +13.2% | 236,696 | -3.3% | 0.12% | +12.7% |
| Q4 2022 | $21,708 | -99.9% | 244,896 | -1.0% | 0.11% | +6.8% |
| Q3 2022 | $19,838,000 | -17.9% | 247,446 | -2.0% | 0.10% | -8.8% |
| Q2 2022 | $24,174,000 | -36.9% | 252,439 | -2.1% | 0.11% | -19.9% |
| Q1 2022 | $38,311,000 | +2.7% | 257,900 | -2.0% | 0.14% | +9.3% |
| Q4 2021 | $37,311,000 | +13.7% | 263,200 | +5.0% | 0.13% | +5.7% |
| Q3 2021 | $32,801,000 | +522.4% | 250,715 | +553.8% | 0.12% | +542.1% |
| Q2 2021 | $5,270,000 | +40438.5% | 38,347 | +39844.8% | 0.02% | – |
| Q1 2021 | $13,000 | +18.2% | 96 | 0.0% | 0.00% | – |
| Q4 2020 | $11,000 | -8.3% | 96 | -36.4% | 0.00% | – |
| Q3 2020 | $12,000 | – | 151 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 310,392 | $34,764,000 | 4.40% |
| Iron Triangle Partners LP | 148,317 | $16,612,000 | 2.15% |
| Ranger Investment Management | 294,664 | $33,002,000 | 1.74% |
| Penn Capital Management Company, LLC | 86,810 | $9,723,000 | 1.23% |
| EARNEST PARTNERS LLC | 1,575,336 | $176,438,000 | 1.22% |
| Champlain Investment Partners, LLC | 1,692,014 | $189,506,000 | 1.09% |
| MOODY ALDRICH PARTNERS LLC | 59,005 | $6,609,000 | 1.07% |
| Hood River Capital Management LLC | 232,412 | $26,030,000 | 0.86% |
| OAK RIDGE INVESTMENTS LLC | 80,775 | $9,047,000 | 0.80% |
| Huber Capital Management LLC | 18,620 | $2,085,000 | 0.68% |